Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - HER2-ADC
Get the latest updates from Google Alert - HER2-ADC directly as they happen.
Follow now 125 followers
Latest posts
Last updated about 2 hours ago
Dr Lopetegui-Lia on Ongoing ADC Research in Metastatic TNBC - OncLive
about 3 hours ago
... ADC composed of an ... Community Practice Connections™: Tailored Treatment Approaches...
Preclinical Activity of Datopotamab Deruxtecan, an Antibody–Drug Conjugate Targeting ...
about 11 hours ago
USC primary tumor cell lines were treated with Dato-DXd and a control...
Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T ...
about 14 hours ago
... ADC Trodelvy® in Metastatic Breast Cancer. Press Release. By: Ref: PR...
Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T ...
1 day ago
... ADC Trodelvy® in Metastatic Breast Cancer. May 8, 2025 |. 4...
Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T ...
1 day ago
... (ADC), in patients with metastatic breast cancer (mBC) ... HER2-negative (HR+/HER2−)...
AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer
1 day ago
AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage...
Enhertu followed by THP before surgery showed statistically significant and clinically ...
1 day ago
DESTINY-Breast11 enrolled 927 patients across multiple sites in Asia, Europe, North America...
Antibody-Drug Conjugates: Next-Level Breast Cancer Treatment - Baptist Health
2 days ago
... ADCs on the market — including those for HER2 ... ADC...
AstraZeneca, Daiichi's Enhertu extends winning streak in breast cancer trials, this time in ...
2 days ago
Last month, the ADC also demonstrated a progression-free survival benefit in previously...
ENHERTU® Followed by THP Before Surgery Showed Statistically Significant and Clinically ...
2 days ago
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC)...
First Win For AstraZeneca's Enhertu In Early-Stage Breast Cancer Treatment
2 days ago
... HER2-positive patients ... (ADC) helped eliminate all signs of disease from...
Mersana makes Emi-Le the one, laying off 55% of staff to narrow focus to B7-H4 ADC
3 days ago
GSK paid $100 million upfront for an option on the HER2-directed ADC...